• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Epidemiologic investigation of nonmelanoma skin cancer mortality: the Rhode Island Follow-Back Study.

作者信息

Weinstock M A

机构信息

Dermatoepidemiology Unit, V.A. Medical Center, Roger Williams Medical Center, Providence, Rhode Island.

出版信息

J Invest Dermatol. 1994 Jun;102(6):6S-9S. doi: 10.1111/1523-1747.ep12385735.

DOI:10.1111/1523-1747.ep12385735
PMID:8006441
Abstract

The Rhode Island Follow-Back Study was initiated to elucidate the magnitude and characteristics of nonmelanoma skin cancer mortality. All deaths reported among Rhode Island residents during 1979 through 1987 and attributed to nonmelanoma skin cancer were investigated and medical records sought. Most were misclassified, primarily due to squamous cell carcinoma of mucosal surfaces in the head and neck. In Rhode Island and nationally, this source of misclassification is increasingly frequent. Appropriate adjustment of national statistics for misclassification reveals a consistent decline in nonmelanoma skin cancer mortality rates from 1969 through 1988, although the actual numbers of deaths are increasing due to growth and aging of the population. Examination of the records of those Rhode Island residents who did die from nonmelanoma skin cancer demonstrated that most had squamous cell carcinoma, and many of those arose from the ear. These analyses suggest that particular emphasis should be placed on the ear in public health campaigns geared toward the prevention and early detection of nonmelanoma skin cancer.

摘要

相似文献

1
Epidemiologic investigation of nonmelanoma skin cancer mortality: the Rhode Island Follow-Back Study.
J Invest Dermatol. 1994 Jun;102(6):6S-9S. doi: 10.1111/1523-1747.ep12385735.
2
Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.非黑色素瘤皮肤癌死亡率(1988 - 2000年):罗德岛随访研究
Arch Dermatol. 2004 Jul;140(7):837-42. doi: 10.1001/archderm.140.7.837.
3
Nonmelanoma skin cancer mortality. A population-based study.非黑色素瘤皮肤癌死亡率。一项基于人群的研究。
Arch Dermatol. 1991 Aug;127(8):1194-7.
4
Inaccuracies in certification of nonmelanoma skin cancer deaths.非黑色素瘤皮肤癌死亡证明中的不准确之处。
Am J Public Health. 1992 Feb;82(2):278-81. doi: 10.2105/ajph.82.2.278.
5
Clinical Outcomes of Free, Public Skin Cancer Screening Events, Rhode Island, 2015-2019.2015-2019 年,罗得岛免费公共皮肤癌筛查活动的临床结果。
R I Med J (2013). 2021 Aug 2;104(6):22-27.
6
Nonmelanoma skin cancer in the United States: incidence.美国非黑色素瘤皮肤癌:发病率
J Am Acad Dermatol. 1994 May;30(5 Pt 1):774-8. doi: 10.1016/s0190-9622(08)81509-5.
7
Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.非黑色素瘤皮肤癌与全因死亡率及癌症相关死亡率风险:一项系统综述
Arch Dermatol Res. 2017 May;309(4):243-251. doi: 10.1007/s00403-017-1724-5. Epub 2017 Mar 11.
8
Childhood Cancer in Rhode Island.罗德岛州的儿童癌症
R I Med J (2013). 2019 Feb 1;102(1):46-49.
9
Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report.夏威夷考艾岛日本裔夏威夷人的非黑色素瘤皮肤癌:发病率报告。
J Am Acad Dermatol. 1995 Sep;33(3):422-6. doi: 10.1016/0190-9622(95)91387-4.
10
The risk of developing subsequent nonmelanoma skin cancers.发生后续非黑色素瘤皮肤癌的风险。
J Am Acad Dermatol. 1990 Dec;23(6 Pt 1):1114-8. doi: 10.1016/0190-9622(90)70343-g.

引用本文的文献

1
Estrogen deficiency - a central paradigm in age-related impaired healing?雌激素缺乏——与年龄相关的愈合受损的核心范例?
EXCLI J. 2021 Jan 11;20:99-116. doi: 10.17179/excli2020-3210. eCollection 2021.
2
Emerging concepts and recent advances in basal cell carcinoma.基底细胞癌的新兴概念与最新进展
F1000Res. 2017 Dec 4;6:2085. doi: 10.12688/f1000research.11314.1. eCollection 2017.
3
Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC).皮肤鳞状细胞癌(SCC)/神经内分泌[默克尔细胞]癌(MCC)合并症的临床和皮肤镜特征。
J Am Acad Dermatol. 2015 Dec;73(6):968-75. doi: 10.1016/j.jaad.2015.08.041. Epub 2015 Oct 2.
4
Transient receptor potential vanilloid 4 (TRPV4) is downregulated in keratinocytes in human non-melanoma skin cancer.瞬时受体电位香草酸 4 型(TRPV4)在人类非黑素瘤皮肤癌的角质形成细胞中下调。
J Invest Dermatol. 2014 Sep;134(9):2408-2417. doi: 10.1038/jid.2014.145. Epub 2014 Mar 18.
5
Estrogens and aging skin.雌激素与皮肤老化
Dermatoendocrinol. 2013 Apr 1;5(2):264-70. doi: 10.4161/derm.23872.
6
Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin--a case-control study.日光暴露模式和时间与皮肤基底细胞癌和鳞状细胞癌风险的关系——一项病例对照研究。
BMC Cancer. 2012 Sep 20;12:417. doi: 10.1186/1471-2407-12-417.
7
Molecular markers in cutaneous squamous cell carcinoma.皮肤鳞状细胞癌中的分子标志物
Int J Surg Oncol. 2011;2011:231475. doi: 10.1155/2011/231475. Epub 2011 Aug 9.
8
Focus Issue on Squamous Cell Carcinoma: Practical Concerns Regarding the 7th Edition AJCC Staging Guidelines.鳞状细胞癌焦点问题:关于美国癌症联合委员会(AJCC)第7版分期指南的实际考量
J Skin Cancer. 2011;2011:156391. doi: 10.1155/2011/156391. Epub 2010 Nov 22.
9
Metatypical basal cell carcinoma: a clinical review.异型基底细胞癌:临床综述
J Exp Clin Cancer Res. 2008 Nov 7;27(1):65. doi: 10.1186/1756-9966-27-65.
10
Effect of estrogens on skin aging and the potential role of SERMs.雌激素对皮肤衰老的影响及选择性雌激素受体调节剂的潜在作用。
Clin Interv Aging. 2007;2(3):283-97. doi: 10.2147/cia.s798.